[["patients with advanced congestive heart failure", "have", "altered thyroid hormone metabolism"], ["low triiodothyronine level", "is associated with", "impaired hemodynamics"], ["low triiodothyronine level", "is an independent predictor of", "poor survival"], ["this study", "sought to evaluate", "safety and hemodynamic effects of short-term intravenous administration of triiodothyronine"], ["intravenous bolus dose of triiodothyronine", "was administered to", "23 patients with advanced heart failure"], ["mean left ventricular ejection fraction", "is", "0.22 +/- 0.01"], ["cardiac rhythm and hemodynamic status", "were monitored for", "12 hours"], ["basal metabolic rate", "was measured by", "indirect calorimetry"], ["echocardiographic parameters", "were measured at", "baseline and at 4 to 6 hours"], ["triiodothyronine", "was well tolerated without", "episodes of ischemia or clinical arrhythmia"], ["", "", ""], ["", "", ""], ["cardiac output", "increased with", "a reduction in systemic vascular resistance"], ["reduction in systemic vascular resistance", "is consistent with", "a peripheral vasodilatory effect"], ["acute intravenous administration of triiodothyronine", "is well tolerated in", "patients with advanced heart failure"], ["acute intravenous administration of triiodothyronine", "establishes the basis for", "further investigation into safety and potential hemodynamic benefits"], ["further investigation", "includes", "longer infusions"], ["further investigation", "includes", "combined infusion with inotropic agents"], ["further investigation", "includes", "oral triiodothyronine replacement therapy"], ["further investigation", "includes", "new triiodothyronine analogs"]]